tiprankstipranks
Trending News
More News >
Astellas Pharma Inc (JP:4503)
:4503

Astellas Pharma (4503) Revenue

Compare
3 Followers

Astellas Pharma Revenue

Astellas Pharma had a revenue of 517.41B in the quarter ending Dec 31, 2024, with 11.87%. This bring the company's revenue in the last twelve months to 1.87T, Decreased 5.39%. In the fiscal year ending Mar 31, 2024, Astellas Pharma had annual revenue of 1.60T with 5.60% growth.
Revenue (ttm)
1.87T
Revenue Growth
21.01%
P/S Ratio
1.43
Revenue/Employee
$108,694,049
Employees
14,754
Market Cap
$2.29T

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 20241.60T85.05B+5.60%
Mar 31, 20231.52T222.46B+17.16%
Mar 31, 20221.30T46.63B+3.73%
Mar 31, 20211.25T-51.31B-3.94%
Mar 31, 20201.30T-5.50B-0.42%
Mar 31, 20191.31T6.03B+0.46%
Mar 31, 20181.30T-11.35B-0.87%
Mar 31, 20171.31T-61.04B-4.45%
Mar 31, 20161.37T125.45B+10.06%
Mar 31, 20151.25T107.35B+9.42%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis